Abstract

Antiseizure medications (ASMs) are the second most widely prescribed psychotropic for people with intellectual disabilities in England. Multiple psychotropic prescribing is prevalent in almost half of people with intellectual disabilities on ASMs. This analysis identifies limited evidence of ASM benefit in challenging behaviour management and suggests improvements needed to inform clinical practice.

DOI

10.1192/bjp.2022.182

Publication Date

2023-02-14

Publication Title

British Journal of Psychiatry

Volume

222

Issue

5

ISSN

0007-1250

Organisational Unit

Peninsula Medical School

Share

COinS